Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)

首次发布于 2019 年 9 月 6 日

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

计划入组 9 人 · 首次发布于 2004 年 1 月 15 日

Evaluating the Outcome of Cardio Selective beta1- Blockers Use in Patients With Copd

计划入组 30 人 · 首次发布于 2021 年 4 月 14 日

TGF-beta1 (Hoechst)

protein kinase A activator + beta1 adrenergic receptor antagonist

2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE

C₃₇H₅₉N₇O₂₀

Beta Bionics

Beta Innov

France

Cerevance Beta, Inc.

ASG's Beta1 Becomes First Inhaled Erectile Dysfunction Therapy to Receive FDA IND Approval

REDUCE-AMI Trial Re-evaluates Beta-Blocker Use Post-Myocardial Infarction

Beta-Blockers Offer New Hope for Huntington's Disease Patients